ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Respiratory Distress Syndrome Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-30X5534
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Respiratory Distress Syndrome Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Respiratory Distress Syndrome Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-30X5534
Report
July 2025
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Chiesi Farmaceutici
CR Double-Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen

Respiratory Distress Syndrome Market Size

In 2024, the global market size of Respiratory Distress Syndrome was estimated to be worth US$ 420 million and is forecast to reach approximately US$ 608 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.

Respiratory Distress Syndrome Market

Respiratory Distress Syndrome Market

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Respiratory Distress Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Distress Syndrome.
The Respiratory Distress Syndrome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Distress Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Distress Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Respiratory Distress Syndrome Market Report

Report Metric Details
Report Name Respiratory Distress Syndrome Market
Forecasted market size in 2031 approximately US$ 608 million
CAGR 5.5%
Forecasted years 2025 - 2031
Segment by Type
  • Poractant Alfa
  • Beractant
  • Calfactant
  • Others
Segment by Application
  • Very Preterm Infants
  • Moderate to Late Preterm Infants
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Respiratory Distress Syndrome in global and regional level.
  • Chapter 3: Detailed analysis of Respiratory Distress Syndrome company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Respiratory Distress Syndrome revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Respiratory Distress Syndrome Market size in 2031?

Ans: The Respiratory Distress Syndrome Market size in 2031 will be approximately US$ 608 million.

What is the Respiratory Distress Syndrome Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 33% .

What is the market share of major companies in Respiratory Distress Syndrome Market?

Ans: Top 3 companies occupied about 85% market share.

Who are the main players in the Respiratory Distress Syndrome Market report?

Ans: The main players in the Respiratory Distress Syndrome Market are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen

What are the Application segmentation covered in the Respiratory Distress Syndrome Market report?

Ans: The Applications covered in the Respiratory Distress Syndrome Market report are Very Preterm Infants, Moderate to Late Preterm Infants, Others

What are the Type segmentation covered in the Respiratory Distress Syndrome Market report?

Ans: The Types covered in the Respiratory Distress Syndrome Market report are Poractant Alfa, Beractant, Calfactant, Others

1 Study Coverage
1.1 Respiratory Distress Syndrome Product Introduction
1.2 Market by Type
1.2.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Poractant Alfa
1.2.3 Beractant
1.2.4 Calfactant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Very Preterm Infants
1.3.3 Moderate to Late Preterm Infants
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Respiratory Distress Syndrome Market Size Estimates and Forecasts
2.2 Respiratory Distress Syndrome Market Size by Region: 2024 Versus 2031
2.2.1 Global Respiratory Distress Syndrome Revenue by Region: 2020-2025
2.2.2 Global Respiratory Distress Syndrome Revenue Forecast by Region (2026-2031)
2.2.3 Global Respiratory Distress Syndrome Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Respiratory Distress Syndrome Revenue by Type (2020-2031)
3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Respiratory Distress Syndrome Revenue by Application (2020-2031)
3.2.2 Global Respiratory Distress Syndrome Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Poractant Alfa of Respiratory Distress Syndrome Revenue Market Share by Application
3.3.2 Beractant of Respiratory Distress Syndrome Revenue Market Share by Application
3.3.3 Calfactant of Respiratory Distress Syndrome Revenue Market Share by Application
3.3.4 Others of Respiratory Distress Syndrome Revenue Market Share by Application
4 Global Respiratory Distress Syndrome by Company
4.1 Global Respiratory Distress Syndrome Revenue by Company (2020-2025)
4.2 Global Respiratory Distress Syndrome Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Respiratory Distress Syndrome Companies around the World: Ranking by Revenue
4.3.2 Global Respiratory Distress Syndrome Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Respiratory Distress Syndrome Companies Headquarters & Product Type
4.4.1 Global Respiratory Distress Syndrome Companies Headquarters
4.4.2 Date of International Companies Enter into Respiratory Distress Syndrome Market
4.4.3 Global Respiratory Distress Syndrome Companies Product & Service
4.4.4 Poractant Alfa Revenue Market Share of Respiratory Distress Syndrome by Company
4.4.5 Beractant Revenue Market Share of Respiratory Distress Syndrome by Company
4.4.6 Calfactant Revenue Market Share of Respiratory Distress Syndrome by Company
4.4.7 Others Revenue Market Share of Respiratory Distress Syndrome by Company
4.5 Global Respiratory Distress Syndrome Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Chiesi Farmaceutici
5.1.1 Chiesi Farmaceutici Corporation Information
5.1.2 Chiesi Farmaceutici Description, Business Overview
5.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Products Offered
5.1.4 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.1.5 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue by Product in 2024
5.1.6 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue by Application in 2024
5.1.7 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.1.8 Chiesi Farmaceutici Recent Developments
5.2 CR-Double Crane
5.2.1 CR-Double Crane Corporation Information
5.2.2 CR-Double Crane Description, Business Overview
5.2.3 CR-Double Crane Respiratory Distress Syndrome Products Offered
5.2.4 CR-Double Crane Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.2.5 CR-Double Crane Respiratory Distress Syndrome Revenue by Product in 2024
5.2.6 CR-Double Crane Respiratory Distress Syndrome Revenue by Application in 2024
5.2.7 CR-Double Crane Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.2.8 CR-Double Crane Recent Developments
5.3 ONY Biotech
5.3.1 ONY Biotech Corporation Information
5.3.2 ONY Biotech Description, Business Overview
5.3.3 ONY Biotech Respiratory Distress Syndrome Products Offered
5.3.4 ONY Biotech Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.3.5 ONY Biotech Respiratory Distress Syndrome Revenue by Product in 2024
5.3.6 ONY Biotech Respiratory Distress Syndrome Revenue by Application in 2024
5.3.7 ONY Biotech Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.3.8 ONY Biotech Recent Developments
5.4 AbbVie
5.4.1 AbbVie Corporation Information
5.4.2 AbbVie Description, Business Overview
5.4.3 AbbVie Respiratory Distress Syndrome Products Offered
5.4.4 AbbVie Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.4.5 AbbVie Respiratory Distress Syndrome Revenue by Product in 2024
5.4.6 AbbVie Respiratory Distress Syndrome Revenue by Application in 2024
5.4.7 AbbVie Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.4.8 AbbVie Recent Developments
5.5 Yuhan Corporation
5.5.1 Yuhan Corporation Corporation Information
5.5.2 Yuhan Corporation Description, Business Overview
5.5.3 Yuhan Corporation Respiratory Distress Syndrome Products Offered
5.5.4 Yuhan Corporation Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.5.5 Yuhan Corporation Respiratory Distress Syndrome Revenue by Product in 2024
5.5.6 Yuhan Corporation Respiratory Distress Syndrome Revenue by Application in 2024
5.5.7 Yuhan Corporation Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.5.8 Yuhan Corporation Recent Developments
5.6 JW Pharmaceuticals
5.6.1 JW Pharmaceuticals Corporation Information
5.6.2 JW Pharmaceuticals Description, Business Overview
5.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Products Offered
5.6.4 JW Pharmaceuticals Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.6.5 JW Pharmaceuticals Respiratory Distress Syndrome Revenue by Product in 2024
5.6.6 JW Pharmaceuticals Respiratory Distress Syndrome Revenue by Application in 2024
5.6.7 JW Pharmaceuticals Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.6.8 JW Pharmaceuticals Recent Developments
5.7 Noargen
5.7.1 Noargen Corporation Information
5.7.2 Noargen Description, Business Overview
5.7.3 Noargen Respiratory Distress Syndrome Products Offered
5.7.4 Noargen Respiratory Distress Syndrome Revenue and Gross Margin (2020-2025)
5.7.5 Noargen Respiratory Distress Syndrome Revenue by Product in 2024
5.7.6 Noargen Respiratory Distress Syndrome Revenue by Application in 2024
5.7.7 Noargen Respiratory Distress Syndrome Revenue by Geographic Area in 2024
5.7.8 Noargen Recent Developments
6 North America
6.1 North America Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
6.2 North America Respiratory Distress Syndrome Market Facts & Figures by Country (2020-2031)
6.3 North America Respiratory Distress Syndrome Revenue by Type (2020-2025)
6.4 North America Respiratory Distress Syndrome Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Respiratory Distress Syndrome Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Respiratory Distress Syndrome Revenue by Type (2020-2025)
7.4 Asia-Pacific Respiratory Distress Syndrome Revenue by Application (2020-2025)
8 Europe
8.1 Europe Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
8.2 Europe Respiratory Distress Syndrome Market Facts & Figures by Country (2020-2031)
8.3 Europe Respiratory Distress Syndrome Revenue by Type (2020-2025)
8.4 Europe Respiratory Distress Syndrome Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
9.2 Latin America Respiratory Distress Syndrome Market Facts & Figures by Country (2020-2031)
9.3 Latin America Respiratory Distress Syndrome Revenue by Type (2020-2025)
9.4 Latin America Respiratory Distress Syndrome Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Respiratory Distress Syndrome Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Respiratory Distress Syndrome Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Respiratory Distress Syndrome Revenue by Type (2020-2025)
10.4 Middle East and Africa Respiratory Distress Syndrome Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Respiratory Distress Syndrome Supply Chain Analysis
11.2 Respiratory Distress Syndrome Key Raw Materials and Upstream Suppliers
11.3 Respiratory Distress Syndrome Clients Analysis
11.4 Respiratory Distress Syndrome Sales Channel and Sales Model Analysis
11.4.1 Respiratory Distress Syndrome Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Respiratory Distress Syndrome Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Respiratory Distress Syndrome Distributors
12 Respiratory Distress Syndrome Market Dynamics
12.1 Respiratory Distress Syndrome Industry Trends
12.2 Respiratory Distress Syndrome Market Drivers
12.3 Respiratory Distress Syndrome Market Challenges
12.4 Respiratory Distress Syndrome Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Chiesi Farmaceutici
CR Double-Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
List of Tables
 Table 1. Global Respiratory Distress Syndrome Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Respiratory Distress Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Respiratory Distress Syndrome Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Respiratory Distress Syndrome Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Respiratory Distress Syndrome Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Respiratory Distress Syndrome Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Respiratory Distress Syndrome Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Respiratory Distress Syndrome Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Respiratory Distress Syndrome Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Respiratory Distress Syndrome Players by Revenue (US$ Million) in 2024
 Table 13. Global Respiratory Distress Syndrome Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Respiratory Distress Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Distress Syndrome as of 2024)
 Table 15. Global Respiratory Distress Syndrome Companies Headquarters
 Table 16. Date of International Companies Enter into Respiratory Distress Syndrome Market
 Table 17. Global Respiratory Distress Syndrome Companies Product & Service
 Table 18. Global Respiratory Distress Syndrome Mergers & Acquisitions, Expansion Plans
 Table 19. Chiesi Farmaceutici Corporation Information
 Table 20. Chiesi Farmaceutici Description and Business Overview
 Table 21. Chiesi Farmaceutici Respiratory Distress Syndrome Product
 Table 22. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Chiesi Farmaceutici Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
 Table 24. Chiesi Farmaceutici Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
 Table 25. Chiesi Farmaceutici Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
 Table 26. Chiesi Farmaceutici Recent Developments
 Table 27. CR-Double Crane Corporation Information
 Table 28. CR-Double Crane Description and Business Overview
 Table 29. CR-Double Crane Respiratory Distress Syndrome Product
 Table 30. CR-Double Crane Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. CR-Double Crane Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
 Table 32. CR-Double Crane Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
 Table 33. CR-Double Crane Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
 Table 34. CR-Double Crane Recent Developments
 Table 35. ONY Biotech Corporation Information
 Table 36. ONY Biotech Description and Business Overview
 Table 37. ONY Biotech Respiratory Distress Syndrome Product
 Table 38. ONY Biotech Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. ONY Biotech Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
 Table 40. ONY Biotech Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
 Table 41. ONY Biotech Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
 Table 42. ONY Biotech Recent Developments
 Table 43. AbbVie Corporation Information
 Table 44. AbbVie Description and Business Overview
 Table 45. AbbVie Respiratory Distress Syndrome Product
 Table 46. AbbVie Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. AbbVie Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
 Table 48. AbbVie Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
 Table 49. AbbVie Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
 Table 50. AbbVie Recent Developments
 Table 51. Yuhan Corporation Corporation Information
 Table 52. Yuhan Corporation Description and Business Overview
 Table 53. Yuhan Corporation Respiratory Distress Syndrome Product
 Table 54. Yuhan Corporation Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Yuhan Corporation Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
 Table 56. Yuhan Corporation Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
 Table 57. Yuhan Corporation Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
 Table 58. Yuhan Corporation Recent Developments
 Table 59. JW Pharmaceuticals Corporation Information
 Table 60. JW Pharmaceuticals Description and Business Overview
 Table 61. JW Pharmaceuticals Respiratory Distress Syndrome Product
 Table 62. JW Pharmaceuticals Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. JW Pharmaceuticals Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
 Table 64. JW Pharmaceuticals Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
 Table 65. JW Pharmaceuticals Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
 Table 66. JW Pharmaceuticals Recent Developments
 Table 67. Noargen Corporation Information
 Table 68. Noargen Description and Business Overview
 Table 69. Noargen Respiratory Distress Syndrome Product
 Table 70. Noargen Respiratory Distress Syndrome Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Noargen Revenue Proportion of Respiratory Distress Syndrome by Product in 2024
 Table 72. Noargen Revenue Proportion of Respiratory Distress Syndrome by Application in 2024
 Table 73. Noargen Revenue Proportion of Respiratory Distress Syndrome by Geographic Area in 2024
 Table 74. Noargen Recent Developments
 Table 75. North America Respiratory Distress Syndrome Revenue by Country (2020-2025) & (US$ Million)
 Table 76. North America Respiratory Distress Syndrome Revenue by Country (2026-2031) & (US$ Million)
 Table 77. North America Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
 Table 78. North America Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
 Table 79. Asia-Pacific Respiratory Distress Syndrome Revenue by Region (2020-2025) & (US$ Million)
 Table 80. Asia-Pacific Respiratory Distress Syndrome Revenue by Region (2026-2031) & (US$ Million)
 Table 81. Asia-Pacific Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
 Table 82. Asia-Pacific Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
 Table 83. Europe Respiratory Distress Syndrome Revenue by Country (2020-2025) & (US$ Million)
 Table 84. Europe Respiratory Distress Syndrome Revenue by Country (2026-2031) & (US$ Million)
 Table 85. Europe Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
 Table 86. Europe Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
 Table 87. Latin America Respiratory Distress Syndrome Revenue by Country (2020-2025) & (US$ Million)
 Table 88. Latin America Respiratory Distress Syndrome Revenue by Country (2026-2031) & (US$ Million)
 Table 89. Latin America Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
 Table 90. Latin America Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
 Table 91. Middle East and Africa Respiratory Distress Syndrome Revenue by Country (2020-2025) & (US$ Million)
 Table 92. Middle East and Africa Respiratory Distress Syndrome Revenue by Country (2026-2031) & (US$ Million)
 Table 93. Middle East and Africa Respiratory Distress Syndrome Revenue by Type (2020-2025) & (US$ Million)
 Table 94. Middle East and Africa Respiratory Distress Syndrome Revenue by Application (2020-2025) & (US$ Million)
 Table 95. Respiratory Distress Syndrome Key Raw Materials, Industry Status and Trend
 Table 96. Respiratory Distress Syndrome Key Raw Materials and Upstream Suppliers
 Table 97. Respiratory Distress Syndrome Clients Status and Trend
 Table 98. Respiratory Distress Syndrome Typical Clients
 Table 99. Respiratory Distress Syndrome Distributors
 Table 100. Respiratory Distress Syndrome Market Trends
 Table 101. Respiratory Distress Syndrome Market Drivers
 Table 102. Respiratory Distress Syndrome Market Challenges
 Table 103. Respiratory Distress Syndrome Market Restraints
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources


List of Figures
 Figure 1. Respiratory Distress Syndrome Product Picture
 Figure 2. Global Respiratory Distress Syndrome Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Respiratory Distress Syndrome Revenue Market Share by Type in 2024 & 2031
 Figure 4. Poractant Alfa Product Picture
 Figure 5. Beractant Product Picture
 Figure 6. Calfactant Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Respiratory Distress Syndrome Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 9. Global Respiratory Distress Syndrome Revenue Market Share by Application in 2024 & 2031
 Figure 10. Very Preterm Infants
 Figure 11. Moderate to Late Preterm Infants
 Figure 12. Others
 Figure 13. Respiratory Distress Syndrome Report Years Considered
 Figure 14. Global Respiratory Distress Syndrome Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Respiratory Distress Syndrome Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Respiratory Distress Syndrome Market Size Market Share by Region: 2024 Versus 2031
 Figure 17. Global Respiratory Distress Syndrome Revenue Market Share by Region (2020-2031)
 Figure 18. Global Respiratory Distress Syndrome Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Global Respiratory Distress Syndrome Revenue Market Share Forecast by Application (2020-2031)
 Figure 20. Poractant Alfa of Respiratory Distress Syndrome Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Beractant of Respiratory Distress Syndrome Revenue Market Share by Application, 2024 VS 2031
 Figure 22. Calfactant of Respiratory Distress Syndrome Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Others of Respiratory Distress Syndrome Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Respiratory Distress Syndrome Revenue Share by Company (2024)
 Figure 25. Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Poractant Alfa Revenue Proportion by Company in 2024
 Figure 27. Beractant Revenue Proportion by Company in 2024
 Figure 28. Calfactant Revenue Proportion by Company in 2024
 Figure 29. Others Revenue Proportion by Company in 2024
 Figure 30. North America Respiratory Distress Syndrome Revenue 2020-2031 (US$ Million)
 Figure 31. North America Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
 Figure 32. North America Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
 Figure 33. Asia-Pacific Respiratory Distress Syndrome Revenue 2020-2031 (US$ Million)
 Figure 34. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
 Figure 37. Europe Respiratory Distress Syndrome Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Respiratory Distress Syndrome Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
 Figure 40. Europe Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
 Figure 41. Latin America Respiratory Distress Syndrome Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Respiratory Distress Syndrome Revenue Market Share by Country (2020-2031)
 Figure 43. Latin America Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
 Figure 44. Latin America Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
 Figure 45. Middle East and Africa Respiratory Distress Syndrome Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 46. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Type (2020-2025)
 Figure 48. Middle East and Africa Respiratory Distress Syndrome Revenue Market Share by Application (2020-2025)
 Figure 49. Respiratory Distress Syndrome Supply Chain (Upstream and Downstream Market)
 Figure 50. Global Production Market Share of Respiratory Distress Syndrome Raw Materials by Region in 2024
 Figure 51. Respiratory Distress Syndrome Distribution Channels
 Figure 52. Global Respiratory Distress Syndrome Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 53. Global Respiratory Distress Syndrome Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Acute Respiratory Distress Syndrome Therapeutics Market Research Report 2024
Global Acute Respiratory Distress Syndrome Treatment Device Market Research Report 2024
Neonatal Respiratory Distress Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bronchopulmonary Dysplasia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Neonatal Ventilators Market Insights Forecast to 2030
Global Neonatal Preterm Infant Care Market Insights Forecast to 2030
Global Mechanical Neonatal Ventilators Market Insights Forecast to 2030
Preterm Birth Prevention and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pressure Mode Neonatal Ventilators Market
Breathing Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Preterm Birth Prevention and Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neonatal Noninvasive Ventilator Market Insights Forecast to 2030
Global Eisenmenger Syndrome Treatment Market Research Report 2024
Global Lung Surfactants Market Research Report 2024
Global Acute Respiratory Distress Syndrome Ventilation Treatment Device Market Research Report 2024
Global Neonatal Intensive Care Ventilators Market Insights Forecast to 2030
Global Intensive Care Neonatal Ventilators Market Insights Forecast to 2030
Neonatal Intensive Care Respiratory Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Acute Respiratory Distress Syndrome Device Market Research Report 2024
Volume Mode Neonatal Ventilators Market

RELATED REPORTS

Global Inhaled Treatment for Asthma and COPD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Y19888
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Oxygen Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11D3386
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Chronic Obstructive Pulmonary Disorder (COPD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D2937
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Bronchiectasis Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18E6080
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions